STOCKHOLDERS’ EQUITY (DEFICIT) (Tables)
|
3 Months Ended |
Sep. 30, 2025 |
|---|
| Class of Warrant or Right [Line Items] |
|
| SCHEDULE OF STOCK OPTIONS ACTIVITY |
Activity
in the Company’s stock options during the three months ended September 30, 2025 and related balances outstanding as of that date
are reflected below:
SCHEDULE OF STOCK OPTIONS ACTIVITY
| |
|
Number of Shares |
|
|
Weighted Average Exercise Price |
|
|
Weighted Average Remaining Contract Term
(# years) |
|
|
Aggregate intrinsic Value |
|
|
Weighted Average Grant Date Fair Value |
|
| Outstanding at June 30, 2025 |
|
|
796,660 |
|
|
$ |
4.10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Granted |
|
|
536,660 |
|
|
|
1.88 |
|
|
|
|
|
|
|
|
|
|
$ |
1.23 |
|
| Exercised |
|
|
– |
|
|
|
– |
|
|
|
|
|
|
$ |
– |
|
|
|
|
|
| Forfeited and cancelled |
|
|
(119,439 |
) |
|
|
3.78 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Outstanding at September 30, 2025 |
|
|
1,213,881 |
|
|
|
3.15 |
|
|
|
7.99 |
|
|
|
1,138,000 |
|
|
|
|
|
| Exercisable at September 30, 2025 |
|
|
766,905 |
|
|
|
4.58 |
|
|
|
5.52 |
|
|
|
86,000 |
|
|
|
|
|
Activity
in the Company’s stock options during the three months ended September 30, 2024 and related balances outstanding as of that date
are reflected below:
| |
|
Number of Shares |
|
|
Weighted Average Exercise Price |
|
|
Weighted Average Remaining Contract Term
(# years) |
|
|
Aggregate intrinsic Value |
|
|
Weighted Average Grant Date Fair Value |
|
| Outstanding at June 30, 2024 |
|
|
1,605,060 |
|
|
$ |
4.85 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Granted |
|
|
– |
|
|
|
– |
|
|
|
|
|
|
|
|
|
|
$ |
– |
|
| Exercised |
|
|
– |
|
|
|
– |
|
|
|
|
|
|
$ |
– |
|
|
|
|
|
| Forfeited and cancelled |
|
|
(84,942 |
) |
|
|
3.39 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Outstanding at September 30, 2024 |
|
|
1,520,118 |
|
|
|
4.94 |
|
|
|
7.63 |
|
|
|
|
|
|
|
|
|
| Exercisable at September 30, 2024 |
|
|
420,825 |
|
|
|
8.88 |
|
|
|
4.55 |
|
|
|
|
|
|
|
|
|
|
| SCHEDULE OF FAIR VALUE ASSUMPTIONS OF STOCK OPTIONS |
The
Company uses the Black-Scholes valuation model to calculate the fair value of stock options at the date of grant. Weighted average annualized
percentages and expected term inputs used in Black-Scholes valuations during the periods listed below are:
SCHEDULE OF FAIR VALUE ASSUMPTIONS OF STOCK OPTIONS
| |
|
Three months ended September 30, |
|
| |
|
2025 |
|
|
2024 (1) |
|
| Expected volatility |
|
|
95.46 |
% |
|
|
- |
|
| Risk free interest rate |
|
|
3.85 |
% |
|
|
- |
|
| Dividend yield |
|
|
– |
% |
|
|
- |
|
| Expected term (years) |
|
|
5.87 |
|
|
|
|
|
| (1) |
No stock options were issued during the three months ended
September 30, 2024. |
|
| SCHEDULE OF RESTRICTED STOCK UNITS ACTIVITY |
Activity
in RSUs, including PSUs, during the three months ended September 30, 2025 and related balances outstanding as of that date are reflected
below:
SCHEDULE OF RESTRICTED STOCK UNITS ACTIVITY
| |
|
Number of Shares |
|
|
Weighted Average Grant Date Fair Value |
|
|
Weighted Average Remaining Contract Term (# years) |
|
| Outstanding at June 30, 2025 |
|
|
200,000 |
|
|
$ |
1.60 |
|
|
|
|
|
| Granted |
|
|
304,878 |
|
|
|
1.43 |
|
|
|
|
|
| Vested and settled |
|
|
– |
|
|
|
– |
|
|
|
|
|
| Forfeited and cancelled |
|
|
– |
|
|
|
– |
|
|
|
|
|
| Outstanding at September 30, 2025 |
|
|
504,878 |
|
|
|
1.49 |
|
|
|
1.92 |
|
Activity
in RSUs during the three months ended September 30, 2024 and related balances outstanding as of that date are reflected below:
| |
|
Number of Shares |
|
|
Weighted Average Grant Date Fair Value |
|
| Outstanding at June 30, 2024 |
|
|
114,666 |
|
|
$ |
5.56 |
|
| Granted |
|
|
– |
|
|
|
– |
|
| Vested and settled |
|
|
– |
|
|
|
– |
|
| Forfeited and cancelled |
|
|
– |
|
|
|
– |
|
| Outstanding at September 30, 2024 |
|
|
114,666 |
|
|
|
5.56 |
|
|
| SCHEDULE OF STOCK-BASED COMPENSATION EXPENSES |
The
following table summarizes SBC expense:
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSES
|
|
|
1 |
|
|
|
2 |
|
| |
|
Three months ended September 30, |
|
| |
|
2025 |
|
|
2024 |
|
| Selling and administrative |
|
$ |
210,000 |
|
|
$ |
319,000 |
|
| Research and development |
|
|
(1,000 |
) |
|
|
28,000 |
|
| Total stock-based compensation expense |
|
$ |
209,000 |
|
|
$ |
347,000 |
|
|
| Warrant [Member] |
|
| Class of Warrant or Right [Line Items] |
|
| SCHEDULE OF STOCK WARRANT ACTIVITY |
Activity
in the Company’s common stock warrants during the three months ended September 30, 2025 is reflected below:
SCHEDULE OF STOCK WARRANT ACTIVITY
| |
|
Number of Warrants |
|
|
Weighted Average Exercise Price Per Warrant |
|
|
Weighted Average Remaining Contract Term (# years) |
|
| Outstanding and exercisable at June 30, 2025 |
|
|
1,413,110 |
|
|
$ |
6.14 |
|
|
|
|
|
| Issued |
|
|
1,214,766 |
|
|
|
1.72 |
|
|
|
|
|
| Exercised |
|
|
– |
|
|
|
– |
|
|
|
|
|
| Forfeited and cancelled |
|
|
– |
|
|
|
– |
|
|
|
|
|
| Outstanding and exercisable at September 30, 2025 |
|
|
2,627,876 |
|
|
|
4.10 |
|
|
|
2.95 |
|
Activity
in the Company’s common stock warrants during the three months ended September 30, 2024 is reflected below:
| |
|
Number of Warrants |
|
|
Weighted Average Exercise Price Per Warrant |
|
| Outstanding and exercisable at June 30, 2024 |
|
|
1,413,110 |
|
|
$ |
6.14 |
|
| Issued |
|
|
- |
|
|
|
- |
|
| Exercised |
|
|
- |
|
|
|
- |
|
| Forfeited and cancelled |
|
|
- |
|
|
|
- |
|
| Outstanding and exercisable at September 30, 2024 |
|
|
1,413,110 |
|
|
|
6.14 |
|
|